Active Ingredient: BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
Proprietary Name: ONEXTON
Dosage Form; Route of Administration: GEL; TOPICAL
Strength: 3.75%;EQ 1.2% BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N050819
Product Number: 002
Approval Date: Nov 24, 2014
Applicant Holder Full Name: BAUSCH HEALTH AMERICAS INC
Marketing Status:
Prescription
Patent and Exclusivity Information